Does Removing the Gallbladder Help Fatty Liver?

Removing the gallbladder does not help fatty liver disease and may actually make it worse. Multiple large studies consistently find that people who have had a cholecystectomy face a higher risk of developing nonalcoholic fatty liver disease (NAFLD) than those who keep their gallbladder. The relationship is counterintuitive, because gallbladder surgery is one of the most common operations worldwide and is rarely discussed in connection with liver fat. But the gallbladder plays a more active role in liver metabolism than most people realize, and its absence sets off a chain of changes in bile acid signaling, fat processing, and gut bacteria that can tip the balance toward fatty liver.

What the Data Actually Show

A systematic review and meta-analysis pooling data from studies covering roughly 27 million individuals found that cholecystectomy was associated with a 54 percent increased risk of NAFLD.¹ A separate meta-analysis cited in a recent review reported an even higher odds ratio of 2.14, meaning people who had their gallbladder removed were roughly twice as likely to develop fatty liver compared with matched controls.² These are observational findings, not proof that the surgery itself causes fatty liver. But the signal is large and consistent enough that researchers take it seriously.

A risk-stratified cohort study added more texture. People who had undergone cholecystectomy showed a crude hazard ratio of about 1.48 for developing metabolic-dysfunction-associated steatotic liver disease (the newer name for fatty liver linked to metabolic problems). The risk climbed steeply when gallbladder removal was combined with existing metabolic risk factors like obesity, high blood pressure, or high blood sugar: in people with three or more such risk factors, the hazard ratio jumped to 4.45 compared with people who had neither gallbladder removal nor those risk factors.³ In other words, the surgery alone raises the odds modestly, but when it lands on top of an already stressed metabolism, the effect compounds.

Why Gallbladder Removal Might Promote Fat in the Liver

The gallbladder’s job is to store and concentrate bile between meals, then release a burst of it when you eat. Without a gallbladder, bile drips continuously from the liver into the small intestine in a dilute stream. That sounds like a minor plumbing change, but it reshapes how the liver handles cholesterol and fat in several ways.

First, the bile acid pool shrinks and cycles faster. Classic physiology research found that the cholic acid pool is significantly smaller after cholecystectomy and that bile acids are broken down more quickly in the intestine.⁴ This faster recycling alters the chemical signals the liver receives. Bile acids returning to the liver at persistently low concentrations can trick the liver into thinking it needs to produce more, activating a signaling pathway involving the receptor FXR that ramps up cholesterol-to-bile-acid conversion.⁵ The downstream result is a shift in how the liver processes lipids.

Second, bile acids that accumulate in certain patterns after cholecystectomy appear to interfere with the liver’s ability to burn fat. A 2026 study in mice showed that gallbladder removal suppressed a broad set of genes involved in fatty acid oxidation, the process by which liver cells break down fat for energy. Livers from cholecystectomized mice had more lipid droplets, higher triglyceride levels, higher cholesterol, and lower energy reserves in the form of ATP and glycogen.⁶ The mechanism appears to involve bile acids suppressing a receptor called PPARα that normally activates fat-burning genes. When that receptor is dampened, fatty acids get shunted toward storage as triglycerides rather than being burned for fuel.

Third, an earlier mouse study showed that gallbladder removal increased hepatic triglyceride concentrations by about 25 percent and boosted the liver’s output of very-low-density lipoproteins, the particles that carry fat from the liver into the bloodstream.⁷ Both of these changes point in the same direction: after the gallbladder is gone, the liver accumulates more fat.

Does the Same Thing Happen in Humans?

Mouse physiology does not always translate to people, but a small human study found a similar trend. A pilot study in non-obese patients used MRI to measure liver fat content before cholecystectomy and again two years later. Fat content rose significantly in two of the four liver segments measured, and the average across all four segments increased from about 5.4 percent to 5.8 percent. Control subjects who did not have surgery showed no change.⁸ That increase is modest, but the patients were non-obese, meaning they started with relatively healthy livers. In someone who already carries extra weight or has borderline metabolic health, the same nudge could matter more.

This is consistent with the epidemiological data showing that the combination of cholecystectomy and obesity amplifies the risk. The meta-analysis cited earlier found the odds ratio climbed from 2.14 overall to 2.51 in obese individuals.² That amplifying effect is worth knowing about, because gallstones are much more common in people who are overweight, which means the people most likely to need the surgery are also the ones most vulnerable to its metabolic side effects.

The Chicken-and-Egg Problem

One reason this question is tricky is that gallstones and fatty liver share many of the same underlying causes. Obesity, insulin resistance, high triglycerides, and a sedentary lifestyle all increase the risk of both conditions. So when studies find that people who had cholecystectomies have more fatty liver, skeptics reasonably ask whether the surgery caused the fatty liver or whether the same metabolic profile caused both the gallstones and the fatty liver independently.

The evidence suggests both are true. A study of over 500 patients with NAFLD found that gallstone disease was present in about 20 percent of them and that its prevalence rose sharply with more advanced liver damage, climbing from roughly 15 percent in early fibrosis stages to 56 percent in those with cirrhosis.⁹ The inflammatory form of fatty liver, called NASH, was significantly more common in patients who also had gallstone disease (77 percent versus 56 percent). This tells us that having gallstones is not just a coincidence in fatty liver patients; the two conditions share a deep metabolic connection and each seems to worsen the other.

The human imaging data and animal experiments, though, argue that cholecystectomy adds something beyond shared risk factors. The pilot study in non-obese patients controlled for baseline body weight, and the mouse studies used genetically identical animals on identical diets, isolating the effect of surgery. Both showed fat accumulation after gallbladder removal. So while shared metabolic risk explains part of the association, the surgery itself appears to independently nudge the liver toward fat storage.

Does Cholecystectomy Make Existing Fatty Liver Worse?

If removing the gallbladder promotes new fatty liver, you might expect it to accelerate damage in people who already have the condition. A retrospective study looking at 141 patients with NAFLD found that the timing of cholecystectomy relative to the fatty liver diagnosis did not significantly affect progression to cirrhosis, development of fluid in the abdomen, variceal bleeding, liver cancer, or overall survival over a median follow-up of about five years.¹⁰ That is modestly reassuring for people who already have fatty liver and need gallbladder surgery: the operation may not meaningfully speed up their liver disease. But the study was small and retrospective, so the evidence is thin.

Separately, the same review that reported the elevated odds of NAFLD after cholecystectomy also cited data suggesting a 60 percent higher risk of liver fibrosis and a 73 percent higher risk of cirrhosis in people who had undergone the surgery.² Those numbers come from larger epidemiological datasets, and they paint a less reassuring picture for long-term liver health. The contradiction likely reflects differences in study design and patient populations, but it underscores that the question of progression is not fully resolved.

What Happens to the Gut After Surgery

Bile does not just help digest fat; it shapes the community of bacteria living in your intestines. Constant bile flow after cholecystectomy changes that community in ways researchers are still mapping. One study found that the diversity of gut bacteria was significantly lower in people who had undergone cholecystectomy, with certain species like Blautia obeum and Veillonella parvula more abundant than in controls.¹¹ A separate study using deeper genetic sequencing found a decrease in Bifidobacterium breve and an increase in Ruminococcus gnavus after gallbladder removal, along with increased levels of specific bile acid metabolites in the gut.¹²

These shifts matter because gut bacteria influence how the liver handles fat and inflammation. An imbalanced microbiome, sometimes called dysbiosis, is increasingly recognized as a contributor to fatty liver development. This is one more pathway by which losing the gallbladder may tilt the metabolic landscape toward hepatic fat accumulation, though research connecting the microbiome changes specifically to post-cholecystectomy fatty liver is still in its early stages.

Liver Enzymes After Surgery

If you have your gallbladder removed and then get blood work showing elevated liver enzymes, the numbers alone do not mean the surgery has damaged your liver. A study of laparoscopic cholecystectomy patients found that AST rose roughly 1.8-fold in about 73 percent of patients and ALT rose about 2.2-fold in 82 percent within the first day or two after surgery. Both returned to normal within 72 hours.¹³ A separate study attributed the temporary spike to the pressure effects of the gas used to inflate the abdomen during laparoscopic surgery, which temporarily reduces blood flow through the liver.¹⁴ So a brief enzyme bump right after surgery is normal and not a sign of developing fatty liver.

Persistently elevated liver enzymes weeks or months after surgery are a different story and warrant follow-up, but the post-surgical spike itself is not something to worry about.

What You Can Do If You Have Already Lost Your Gallbladder

Knowing that cholecystectomy raises fatty liver risk is useful only if you can act on it. The most important lever remains the same one that drives fatty liver in general: metabolic health. Maintaining a healthy weight, staying physically active, and managing blood sugar are the primary defenses against hepatic fat accumulation, whether or not you have a gallbladder. The cohort data showing that the risk of post-cholecystectomy fatty liver spikes most dramatically in people with three or more metabolic risk factors reinforces that point: controlling those factors likely narrows the gap substantially.

For bile acid support specifically, ursodeoxycholic acid (UDCA) is a synthetic bile acid that has been studied in the context of fatty liver. A meta-analysis of its use in NAFLD found that it significantly lowered liver enzymes including ALT, AST, and GGT.¹⁵ Lowering liver enzymes suggests reduced liver inflammation, which is a meaningful outcome, though UDCA has not been shown to reverse established steatosis on its own. It is sometimes prescribed off-label after cholecystectomy to help compensate for altered bile acid dynamics, but the evidence base for this specific use remains limited. A study examining UDCA after bariatric surgery found that beyond preventing gallstone formation, it did not produce significant changes in metabolic or inflammatory markers.¹⁶

Should Gallbladder Surgery Be Avoided to Protect the Liver?

Cholecystectomy is performed for good reasons. Gallstones that cause recurrent pain, pancreatitis, or bile duct blockage pose immediate, serious risks. No one should decline necessary surgery out of concern about a future fatty liver risk that can be managed with lifestyle. The practical takeaway is not to avoid surgery but to recognize that the surgery is not a metabolically neutral event. If you have gallbladder removal on your medical history, periodic screening for fatty liver through imaging or liver enzyme panels can catch problems early, especially if you carry other metabolic risk factors.

The idea that removing a diseased gallbladder might simultaneously benefit the liver is a reasonable intuition, but the evidence runs the other way. The gallbladder is not just a passive bag holding bile; it is a metabolic organ whose removal changes how the liver processes cholesterol, handles fat, and communicates with gut bacteria. For people who have already had the surgery, that knowledge makes proactive metabolic management more important, not less.

Postcholecystectomy Symptoms That Mimic Liver Problems

Up to 40 percent of people experience digestive symptoms after gallbladder removal, sometimes called postcholecystectomy syndrome. A systematic review found that persistent symptoms were frequently caused by coexisting conditions rather than the surgery itself, along with residual or newly formed stones in a small fraction of patients. Bloating, right upper abdominal discomfort, and diarrhea after fatty meals are common and can easily be mistaken for liver-related issues. If you develop new digestive complaints after cholecystectomy, fatty liver is one possibility worth investigating, but so are bile salt malabsorption, sphincter of Oddi dysfunction, and other gastrointestinal conditions that happen to overlap in symptoms. Getting a proper workup rather than assuming the worst is the right move.

1
PubMed Central. Cholecystectomy and risk of liver disease: a systematic review and meta-analysis of 27 million individuals
2
PubMed Central. Cholecystectomy and non-alcoholic fatty liver disease: Exploring the hidden connection and implications
3
Scientific Reports. Association between cholecystectomy and the risk of new-onset metabolic dysfunction-associated steatotic liver disease: a risk-stratified cohort study
4
Gut. Enterohepatic circulation of bile acids after cholecystectomy
5
Scientific Reports. Gallbladder removal induces hepatic transcriptional and metabolic shifts with cholesterol dysregulation as a key feature
6
Communications Biology. Cholecystectomy inhibits fasting hepatic fatty acid oxidation in mice
7
PubMed. Cholecystectomy increases hepatic triglyceride content and very-low-density lipoproteins production in mice
8
PubMed Central. Effect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese Hispanic patients: a pilot study
9
PLOS ONE. Gallstone Disease Is Associated with More Severe Liver Damage in Patients with Non-Alcoholic Fatty Liver Disease
10
PubMed Central. Cholecystectomy does not worsen progression or outcomes in non-alcoholic fatty liver disease
11
PubMed Central. The Impact of Cholecystectomy on the Gut Microbiota: A Case-Control Study
12
Nature Communications. Cholecystectomy-related gut microbiota dysbiosis exacerbates colorectal tumorigenesis
13
PubMed Central. Are elevated liver enzymes and bilirubin levels significant after laparoscopic cholecystectomy in the absence of bile duct injury?
14
Pakistan Journal of Medical and Health Sciences. Changes in Liver Function Tests after Laparoscopic Cholecystectomy
15
PubMed Central. Ursodeoxycholic Acid’s Effectiveness in the Management of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
16
PubMed Central. Ursodeoxycholic Acid Use After Bariatric Surgery: Effects on Metabolic and Inflammatory Blood Markers